vedolizumab; adulthood; Alzheimer disease; antiretroviral therapy; autism; big data; biliary tract drainage; bullying; candidemia; Clostridium difficile infection; community care; coronavirus disease 2019; diseases; Editorial; fecal microbiota transplantation; health program; Hepatitis C virus; human; lifestyle modification; mass screening; medical research; mild cognitive impairment; mortality; moyamoya disease; myelooptic neuropathy; nonhuman; obese patient; percutaneous transhepatic drainage; postoperative hemorrhage; revascularization; risk factor; SARS-CoV-2 Delta; symptom; tooth fracture; tooth root; treatment outcome; ulcerative colitis